|
US3773919A
(en)
*
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US5109113A
(en)
*
|
1986-05-02 |
1992-04-28 |
Genentech, Inc. |
Membrane anchor fusion polypeptides
|
|
US4777127A
(en)
*
|
1985-09-30 |
1988-10-11 |
Labsystems Oy |
Human retrovirus-related products and methods of diagnosing and treating conditions associated with said retrovirus
|
|
US5219740A
(en)
*
|
1987-02-13 |
1993-06-15 |
Fred Hutchinson Cancer Research Center |
Retroviral gene transfer into diploid fibroblasts for gene therapy
|
|
US5364768A
(en)
*
|
1987-07-07 |
1994-11-15 |
Farmitalia Carlo Erba S.R.L. |
Process for the preparation of penems
|
|
US5422120A
(en)
*
|
1988-05-30 |
1995-06-06 |
Depotech Corporation |
Heterovesicular liposomes
|
|
US5686579A
(en)
*
|
1988-06-21 |
1997-11-11 |
Hybrisens, Ltd. |
Use of antibody/antigen interactions to protect biologically active proteins and peptides
|
|
ATE174514T1
(de)
*
|
1989-01-23 |
1999-01-15 |
Chiron Corp |
Rekombinante zellen für therapien von infektionen und hyperprolieferative störungen und deren herstellung
|
|
US5703055A
(en)
*
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
US6673776B1
(en)
*
|
1989-03-21 |
2004-01-06 |
Vical Incorporated |
Expression of exogenous polynucleotide sequences in a vertebrate, mammal, fish, bird or human
|
|
JPH03133378A
(ja)
*
|
1989-07-19 |
1991-06-06 |
Modrovich Ivan E |
被験体を安定化させて液体中でのその生物学的活性を保存する方法
|
|
US5644034A
(en)
*
|
1989-08-07 |
1997-07-01 |
Peptide Technology Ltd. |
Tumour necrosis factor binding ligands
|
|
US5240846A
(en)
*
|
1989-08-22 |
1993-08-31 |
The Regents Of The University Of Michigan |
Gene therapy vector for cystic fibrosis
|
|
US5670488A
(en)
*
|
1992-12-03 |
1997-09-23 |
Genzyme Corporation |
Adenovirus vector for gene therapy
|
|
WO1992005254A1
(en)
*
|
1990-09-25 |
1992-04-02 |
Genentech, Inc. |
Novel neurothrophic factor
|
|
US6566091B1
(en)
|
1990-09-25 |
2003-05-20 |
Genentech, Inc. |
Neurotrophic factor
|
|
US5364769A
(en)
*
|
1990-09-25 |
1994-11-15 |
Genentech, Inc. |
Nucleic acid encoding neurotrophic factor four (NT-4), vectors, host cells and methods of production
|
|
US5702906A
(en)
*
|
1990-09-25 |
1997-12-30 |
Genentech, Inc. |
Antibodies to neurotrophic factor-4 (NT-4)
|
|
ATE193600T1
(de)
*
|
1990-11-20 |
2000-06-15 |
Dade Behring Marburg Gmbh |
Verfahren zur stabilisierung von enzym-konjugaten
|
|
US20030134815A1
(en)
*
|
1991-08-20 |
2003-07-17 |
The Govt. Of The U.S.A., As Represented By The Secretary, Department Of Health & Human Services |
Adenovirus mediated transfer of genes to the gastrointestinal tract
|
|
WO1993010218A1
(en)
*
|
1991-11-14 |
1993-05-27 |
The United States Government As Represented By The Secretary Of The Department Of Health And Human Services |
Vectors including foreign genes and negative selective markers
|
|
FR2688514A1
(fr)
*
|
1992-03-16 |
1993-09-17 |
Centre Nat Rech Scient |
Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant.
|
|
AU674881B2
(en)
*
|
1992-09-07 |
1997-01-16 |
Biotechnology And Biological Sciences Research Council, The |
Growth hormone potentiating molecules
|
|
AU4920893A
(en)
*
|
1992-09-14 |
1994-04-12 |
Regeneron Pharmaceuticals, Inc. |
Method of producing analgesia using neurotrophins
|
|
US5349056A
(en)
*
|
1992-10-09 |
1994-09-20 |
Regeneron Pharmaceuticals |
Modified ciliary neurotrophic factors
|
|
IL109280A0
(en)
*
|
1993-04-15 |
1994-07-31 |
Regeneron Pharma |
Neurotrophins for treatment of depression
|
|
US5759573A
(en)
*
|
1993-04-22 |
1998-06-02 |
Depotech Corporation |
Cyclodextrin liposomes encapsulating pharmacologic compounds and methods for their use
|
|
JP2534968B2
(ja)
*
|
1993-05-27 |
1996-09-18 |
チッソ株式会社 |
フラビン還元酵素遺伝子
|
|
US6015686A
(en)
*
|
1993-09-15 |
2000-01-18 |
Chiron Viagene, Inc. |
Eukaryotic layered vector initiation systems
|
|
US5766627A
(en)
*
|
1993-11-16 |
1998-06-16 |
Depotech |
Multivescular liposomes with controlled release of encapsulated biologically active substances
|
|
US5753225A
(en)
*
|
1993-12-03 |
1998-05-19 |
The Regents Of The University Of California |
Antibodies that mimic actions of neurotrophins
|
|
US6024734A
(en)
*
|
1994-03-31 |
2000-02-15 |
Brewitt; Barbara A. |
Treatment methods using homeopathic preparations of growth factors
|
|
US20030191061A1
(en)
*
|
1994-03-31 |
2003-10-09 |
Brewitt Barbara A. |
Treatment methods using homeopathic preparations of growth factors
|
|
US6436908B1
(en)
*
|
1995-05-30 |
2002-08-20 |
Duke University |
Use of exogenous β-adrenergic receptor and β-adrenergic receptor kinase gene constructs to enhance myocardial function
|
|
US6013517A
(en)
*
|
1994-05-09 |
2000-01-11 |
Chiron Corporation |
Crossless retroviral vectors
|
|
WO1995031183A1
(en)
*
|
1994-05-16 |
1995-11-23 |
Washington University |
Cell membrane fusion composition and method
|
|
MX9606598A
(es)
*
|
1994-06-24 |
1997-05-31 |
Behringwerke Ag |
Procedimiento para la estabilizacion de moleculas, o partes de moleculas, sensibles a la hidrolisis.
|
|
US5770577A
(en)
*
|
1994-11-14 |
1998-06-23 |
Amgen Inc. |
BDNF and NT-3 polypeptides selectively linked to polyethylene glycol
|
|
US6143718A
(en)
*
|
1995-06-07 |
2000-11-07 |
Amylin Pharmaceuticals, Inc. |
Treatment of Type II diabetes mellutis with amylin agonists
|
|
US6090382A
(en)
*
|
1996-02-09 |
2000-07-18 |
Basf Aktiengesellschaft |
Human antibodies that bind human TNFα
|
|
US5780484A
(en)
*
|
1996-11-13 |
1998-07-14 |
Vertex Pharmaceuticals Incorporated |
Methods for stimulating neurite growth with piperidine compounds
|
|
US5840736A
(en)
*
|
1996-11-13 |
1998-11-24 |
Vertex Pharmaceuticals Incorporated |
Methods and compositions for stimulating neurite growth
|
|
EP0942930B1
(en)
|
1996-11-15 |
2007-08-29 |
Genentech, Inc. |
Purification of neurotrophins
|
|
WO1998032458A1
(en)
*
|
1997-01-23 |
1998-07-30 |
Sumitomo Pharmaceuticals Company, Limited |
Remedies for diabetes
|
|
US20030105057A1
(en)
*
|
1997-03-19 |
2003-06-05 |
Yale University |
Methods and compositions for stimulating apoptosis and cell death or for inhibiting cell growth and cell attachment
|
|
US8173127B2
(en)
*
|
1997-04-09 |
2012-05-08 |
Intellect Neurosciences, Inc. |
Specific antibodies to amyloid beta peptide, pharmaceutical compositions and methods of use thereof
|
|
BR9811923A
(pt)
*
|
1997-08-29 |
2000-08-15 |
Vertex Pharma |
Compostos possuindo atividade neuronal
|
|
US6376471B1
(en)
*
|
1997-10-10 |
2002-04-23 |
Johns Hopkins University |
Gene delivery compositions and methods
|
|
US6565874B1
(en)
*
|
1998-10-28 |
2003-05-20 |
Atrix Laboratories |
Polymeric delivery formulations of leuprolide with improved efficacy
|
|
ATE405636T1
(de)
*
|
1999-06-16 |
2008-09-15 |
Boston Biomedical Res Inst |
Immunologische kontrolle des beta-amyloid gehaltes in vivo
|
|
JP2004510684A
(ja)
*
|
1999-07-06 |
2004-04-08 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
神経学的疾患の治療のためのアゾアミノ酸誘導体
|
|
EP1226139A2
(en)
*
|
1999-07-06 |
2002-07-31 |
Vertex Pharmaceuticals Incorporated |
Cyclized amide derivatives for treating or preventing neuronal damage
|
|
EP1200440A1
(en)
*
|
1999-07-06 |
2002-05-02 |
Vertex Pharmaceuticals Incorporated |
Quinuclidine derivatives for treatment of neurological disorders
|
|
WO2001002376A1
(en)
*
|
1999-07-06 |
2001-01-11 |
Vertex Pharmaceuticals Incorporated |
Amino-alkyl derivatives
|
|
JP2003503482A
(ja)
*
|
1999-07-06 |
2003-01-28 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
環化アミノ酸誘導体
|
|
JP2003505508A
(ja)
*
|
1999-07-30 |
2003-02-12 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
非環式又は環式アミド誘導体
|
|
PT1223966E
(pt)
*
|
1999-10-29 |
2003-09-30 |
Biopharm Ges Biotechn Entwickl |
Utilizacao do gdnf para tratamento de defeitos na cornea
|
|
US20030022840A1
(en)
*
|
2000-02-18 |
2003-01-30 |
Michiko Kishino |
Drugs for ameliorating impaired glucose tolerance
|
|
US20030036512A1
(en)
*
|
2000-03-06 |
2003-02-20 |
Tsutomu Nakagawa |
Leptin-resistance amerliorating agents
|
|
PL208113B1
(pl)
|
2000-06-22 |
2011-03-31 |
Genentech Inc |
Agonistyczne przeciwciało monoklonalne anty-trkC, mysie agonistyczne przeciwciało monoklonalne, ludzkie agonistyczne przeciwciało monoklonalne, wyizolowana cząsteczka kwasu nukleinowego kodująca mysie agonistyczne przeciwciało monoklonalne, wyizolowana cząsteczka kwasu nukleinowego kodująca ludzkie przeciwciało anty-trkC, cząsteczka kwasu nukleinowego, linia komórek gospodarza, linia komórek hybrydomy, przeciwciało wytwarzane przez tę linię komórek hybrydomy, wyizolowana cząsteczka kwasu nukleinowego i wektor zawierający tę cząsteczkę kwasu nukleinowego, przeciwciało, polipeptyd, kompozycja
|
|
US7060429B2
(en)
*
|
2001-02-22 |
2006-06-13 |
University Of Maryland, Baltimore |
Treatment of neurodegenerative diseases by altering levels of TrkB isoforms and/or TrkC isoforms
|
|
WO2002102381A1
(en)
*
|
2001-06-14 |
2002-12-27 |
Vertex Pharmaceuticals Incorporated |
Acylic piperazine and piperidine derivatives which are useful for treating neuronal damage
|
|
US6818613B2
(en)
*
|
2001-11-07 |
2004-11-16 |
Ortho-Mcneil Pharmaceutical, Inc. |
Aqueous sustained-release formulations of proteins
|
|
WO2005082401A1
(en)
*
|
2004-02-20 |
2005-09-09 |
Rinat Neuroscience Corp. |
Methods of treating obesity or diabetes using nt-4/5
|